Skip to main content

Supplementary Table S7 from Epidermal growth factor receptor inhibition by cetuximab modulates hypoxia and interferon response genes in head and neck squamous cell carcinoma

Publication ,  Other
Chaudhary, R; Slebos, RJC; Noel, LC; Song, F; Poole, MI; Hoening, DS; Hernandez-Prera, JC; Conejo-Garcia, JR; Guevara, JA; Wang, X; Xie, M ...
May 4, 2023

<p>Supplementary Table S7. Core enriched genes in the TGF-β signaling</p>

Duke Scholars

DOI

Publication Date

May 4, 2023
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chaudhary, R., Slebos, R. J. C., Noel, L. C., Song, F., Poole, M. I., Hoening, D. S., … Chung, C. H. (2023). Supplementary Table S7 from Epidermal growth factor receptor inhibition by cetuximab modulates hypoxia and interferon response genes in head and neck squamous cell carcinoma. https://doi.org/10.1158/2767-9764.22761515
Chaudhary, Ritu, Robbert J. C. Slebos, Leenil C. Noel, Feifei Song, Maria I. Poole, Dirk S. Hoening, Juan C. Hernandez-Prera, et al. “Supplementary Table S7 from Epidermal growth factor receptor inhibition by cetuximab modulates hypoxia and interferon response genes in head and neck squamous cell carcinoma,” May 4, 2023. https://doi.org/10.1158/2767-9764.22761515.
Chaudhary R, Slebos RJC, Noel LC, Song F, Poole MI, Hoening DS, Hernandez-Prera JC, Conejo-Garcia JR, Guevara JA, Wang X, Xie M, Tan AC, Chung CH. Supplementary Table S7 from Epidermal growth factor receptor inhibition by cetuximab modulates hypoxia and interferon response genes in head and neck squamous cell carcinoma. 2023.

DOI

Publication Date

May 4, 2023